Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
Regeneron loses bid to block Amgen's Eylea biosim, sinking shares
After a federal judge blocked the entry of two biosimilars for Eylea, the same judge has rejected Regeneron's bid to block Amgen’s Eylea knockoff.
Kevin Dunleavy
Sep 24, 2024 10:32am
Docs discuss ongoing Humira use, name preferred biosimilars
Sep 24, 2024 7:20am
Coherus' Udenyca in short supply thanks to contractor flub
Sep 17, 2024 2:25pm
Cigna knocks AbbVie's Humira off of some formularies in 2025
Aug 26, 2024 5:45pm
Sandoz raises guidance after another quarter of sales growth
Aug 9, 2024 7:50am
Biogen retains biosimilars as Leqembi plows ahead
Aug 1, 2024 10:15am
